Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001274737-23-000049
Filing Date
2023-05-15
Accepted
2023-05-15 17:16:09
Documents
59
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q exdx-20230331.htm   iXBRL 10-Q 898130
2 EX-31.1 xgn311-33123.htm EX-31.1 12136
3 EX-31.2 xgn312-33123.htm EX-31.2 12115
4 EX-32.1 xgn321-33123.htm EX-32.1 9634
  Complete submission text file 0001274737-23-000049.txt   5230498

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT exdx-20230331.xsd EX-101.SCH 34017
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT exdx-20230331_cal.xml EX-101.CAL 51701
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT exdx-20230331_def.xml EX-101.DEF 199275
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT exdx-20230331_lab.xml EX-101.LAB 523947
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT exdx-20230331_pre.xml EX-101.PRE 330958
53 EXTRACTED XBRL INSTANCE DOCUMENT exdx-20230331_htm.xml XML 793519
Mailing Address 1261 LIBERTY WAY VISTA CA 92081
Business Address 1261 LIBERTY WAY VISTA CA 92081 (760) 560-1501
EXAGEN INC. (Filer) CIK: 0001274737 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39049 | Film No.: 23924339
SIC: 8071 Services-Medical Laboratories